Department of Surgery, Oncology and Gastroenterology DiSCOG, Orthopaedic Clinic, University of Padova, 35128 Padova, Italy.
Department of Neurosciences, Institute of Human Anatomy, University of Padova, 35121 Padova, Italy.
Int J Environ Res Public Health. 2021 Jul 27;18(15):7952. doi: 10.3390/ijerph18157952.
Morton's syndrome (MS) is a common cause of neuropathic chronic forefoot pain, characterised by the development of a swelling of the common digital plantar nerve, whose aetiology is not fully known. There is currently no gold standard of treatment; nonoperative management commonly involves manual therapies, orthoses therapy and infiltrative techniques, while surgery is indicated after failure of conservative measures. The present preliminary study prospectively evaluates patients affected by MS treated by Fascial Manipulation technique (FM), a noninvasive manual therapy, focused on the release of the deep fascia, reducing its stiffness.
Patients with clinical and sonographic diagnosis of MS with at least a 4-month history of neuropathic symptoms underwent a cycle of three weekly FM sessions. Clinical follow-up, including VAS and AOFAS scores, was performed 21 days (T1) and 3 months (T2) after treatment.
Nine patients, among 28 recruited initially, completed the manual therapy sessions and relative follow-up points. This noninvasive pain treatment led to significant improvement of VAS ( = 0.0034) and AOFAS scores ( = 0.0240) at the first follow-up (T1). At 3-month follow-up (T2), both scores decreased slightly, remaining however superior to the pre-treatment values. Only VAS was still significant ( = 0.0184).
Despite the small size of the case series, this pilot study is unique in supporting Fascial Manipulation in the nonoperative treatment of MS. Further studies are needed with a large cohort of gender balanced patients to confirm the encouraging results obtained.
莫顿氏综合征(MS)是一种常见的神经源性慢性前足疼痛的原因,其特征为足底总神经肿胀,其病因尚未完全明确。目前尚无金标准的治疗方法;非手术治疗通常包括手法治疗、矫形器治疗和浸润技术,而手术则是在保守治疗失败后进行的。本初步前瞻性研究评估了接受筋膜手法治疗(FM)的 MS 患者,FM 是一种非侵入性的手法治疗,侧重于深层筋膜的释放,降低其僵硬度。
对至少有 4 个月神经症状史的临床和超声诊断为 MS 的患者进行了为期 3 周的 FM 治疗。治疗后 21 天(T1)和 3 个月(T2)进行临床随访,包括 VAS 和 AOFAS 评分。
在最初招募的 28 名患者中,有 9 名患者完成了手法治疗和相对随访点。这种非侵入性疼痛治疗可使 VAS( = 0.0034)和 AOFAS 评分( = 0.0240)在第一次随访(T1)时显著改善。在 3 个月随访(T2)时,这两个评分略有下降,但仍高于治疗前的水平。只有 VAS 仍有统计学意义( = 0.0184)。
尽管病例系列较小,但这项初步研究在支持筋膜手法治疗 MS 的非手术治疗方面是独特的。需要进一步研究,纳入更多性别均衡的患者队列,以确认获得的令人鼓舞的结果。